Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials

BACKGROUND: Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of psoriasis-related functionality and health-related quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Shikiar, Richard, Bresnahan, Brian W, Stone, Stephen P, Thompson, Christine, Koo, John, Revicki, Dennis A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC269993/
https://www.ncbi.nlm.nih.gov/pubmed/14613569
http://dx.doi.org/10.1186/1477-7525-1-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC269993/
https://www.ncbi.nlm.nih.gov/pubmed/14613569
http://dx.doi.org/10.1186/1477-7525-1-53

Ejemplares similares